Orphan Drug Specialty Firm Offers CRO Services

November 19, 2014

Applied Clinical Trials

Cot? Orphan announced it will now provide CRO services that will help organizations navigate the clinical trials process

Coté Orphan, a regulatory affairs advisory firm specializing in orphan drugs, announced it will now provide CRO services that will help organizations navigate the clinical trials process through the lens of regulatory affairs. With the addition of the CRO services, Coté Orphan provides companies a complete and robust solution to those developing or seeking to develop orphan drugs.

Read the full release here.